Dr. Reddy’s Q4 dips 86% on lower sales, multiple one offs to ₹221 crore
Total revenue from operations of the Hyderabad-headquartered generic drugmaker was lower at ₹7,546.4 crore (₹8,528.4 crore), according to the results prepared as per Indian Accounting Standards (Ind AS)
What's Your Reaction?
